SCHEMBL14764240

SCHEMBL14764240

C=C(C)C(=O)Oc1ccc(C(=O)[Ge](CC)(CC)C(=O)c2ccc(OC(=O)C(=C)C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.56
KMT2A Q03164 7/20 0.46
ATM Q13315 1/20 0.46
ESR1 P03372 2/20 0.42
HIF1A Q16665 2/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.40
APEX1 P27695 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
PARP10 Q53GL7 2/20 0.37
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.34
PARP15 Q460N3 1/20 0.34
PARP14 Q460N5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8835772 0.82 KMT2A (0.64) ELANEKMT2AATMESR1HIF1A
Butane SCHEMBL15309676 0.79 ELANE (0.61) ELANEKMT2AATMESR1HIF1A
SCHEMBL8835840 0.79 ELANE (0.58) ELANEKMT2AATMESR1HIF1A
SCHEMBL56436 0.79 ELANE (0.69) ELANEKMT2AATMSMN1; SMN2POLB
SCHEMBL14048482 0.79 ELANE (0.61) ELANEKMT2AATMESR1HIF1A
SCHEMBL1320881 0.78 ELANE (0.65) ELANEKMT2AATMESR1HIF1A
SCHEMBL8966108 0.78 ELANE (0.69) ELANEKMT2AATMSMN1; SMN2POLB
SCHEMBL15064112 0.78 ELANE (0.86) ELANEKMT2AATMMAPTRAB9A
SCHEMBL15087045 0.78 ELANE (0.69) ELANEKMT2AATMESR1HIF1A
SCHEMBL13133147 0.78 ELANE (0.69) ELANEKMT2AATMESR1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9668946-B2 Dental materials based on monomers having debonding-on-demand properties IVOCLAR VIVADENT AG (LI) 2017-06-06 US disclosed
US-20140329929-A1 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES IVOCLAR VIVADENT AG (LI) 2014-11-06 US disclosed
WO-2013034777-A2 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES IVOCLAR VIVADENT AG (LI) 2013-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329929-A1 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES RCOR3, NR2E1, RER1 ELANE 4068/4885KMT2A 417/4885ATM 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.